Susana M. Campos, MD, MPH, on the Role of PARP Inhibitors in the Treatment Landscape of Ovarian Cancer

Posted: Thursday, April 26, 2018

Susana M. Campos, MD, MPH, of Dana-Farber Cancer Institute, discusses the use of PARP inhibitors in ovarian cancer and the implications for treatment going forward.